Status:
TERMINATED
Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking Cessation
Eligibility:
All Genders
18-85 years
Phase:
PHASE1
Brief Summary
Eligible participants will be randomized to either: 1) standard care (i.e., 4 counseling sessions and nicotine replacement therapy (NRT)) or 2) standard care + contingency management (i.e., 4 counseli...
Detailed Description
Participants will be recruited through the Thoracic Oncology Program and the Head and Neck Cancers Program. At the time of their initial surgical consultation, surgeons and their support staff in the ...
Eligibility Criteria
Inclusion
- Age 18 or older,
- smoking 5 or more cigarettes per day, and
- diagnosed with any type of head, neck, or thoracic cancer,
- agreement on a 3-week pre-surgical tobacco intervention by both patient and surgeon.
Exclusion
- Unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, severe alcohol dependence, or dementia,
- history of allergic reactions to adhesives,
- females of childbearing potential who are pregnant, nursing, or not practicing effective contraception.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01479998
Start Date
November 1 2011
End Date
June 1 2013
Last Update
March 9 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale-New Haven Hospital
New Haven, Connecticut, United States, 06510
2
Yale Cancer Center
New Haven, Connecticut, United States, 06615